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Abstract  
Background:  Patient-reported outcomes measures in clinical trials ensure that evaluations of 
effectiveness focus on outcomes that are important to patients. In relapsing-remitting conditions 
such as eczema, repeated measurements may allow a more accurate reflection of disease burden 
and treatment effect than less frequent measurements.  
We asked parents/carers of children with eczema taking part in a trial of bath emollients to 
complete weekly questionnaires for 16 weeks.  
Methods:  
The objective of this study was to determine the acceptability and practicality of collecting weekly 
measures of eczema severity online for 16 weeks in children aged 1 to 11 years as part of the BATHE 
study. 
BATHE randomised patients to bath emollients plus standard eczema care or standard eczema care 
only. The primary outcome was eczema severity, measured by the 7-item Patient-Oriented Eczema 
Measure (POEM) repeated weekly for 16 weeks. Acceptability was explored through qualitative 
interviews with ten participants. Interviews were audio-recorded, transcribed, and analysed 
thematically.  Practicality was assessed by exploring the completeness of the data and keeping a log 
of any problems.   
Results:  482 participants were recruited to the trial and 429 opted to complete measures online 
(89.0%).  Data were collected online for 83% of timepoints over the 16 week period and there was 
no association between socio-demographic characteristics and data completeness.  206 (48%) 
completed their weekly data every week for 16 weeks and 341 (79%) completed it at least 80% of 
the time. The mean number of weeks completed was 13.3 out of 16 (s.d 4.2) 
Interviewees said they understood the rationale behind weekly collection and some welcomed this 
as it helped theŵ ƌealise hoǁ theiƌ Đhild’s eĐzeŵa ĐhaŶged ǁeekly. While some interviewees spoke 
of weekly questionnaires as onerous, others said they found them quick and easy. Reminders were 
welcomed.  
Parents/carers seemed happy to receive telephone reminders and it was sometimes useful for 
eliciting problems relating to obtaining trial medication or password problems for online data 
collection.  
Conclusions: Amongst this population, high levels of data completeness suggests that weekly 
completion of the online questionnaire appears to be acceptable and feasible over a 16 week period. 
Trial registration number: ISRCTN84102309, Registered on 9/12/2013 
Key words: feasibility, repeated measures, trial methodology, eczema, atopic dermatitis, POEM, 
PROMs 
 
  
 Background: 
Repeated measures are frequently used in clinical trials rather than a single endpoint in order to 
allow researchers to explore how treatment or the trajectory of a condition change over time. (1) 
Repeated measures also allow for increased power due to the reduced intra-participant variability, 
which results in smaller sample size requirements (1, 2) .  Whilst regular measurements may help to 
give a more accurate impression of changing disease states, this must be balanced against the 
feasibility of doing so within a trial context and the burden it places upon participants and research 
staff to ensure these measures are completed.    
Eczema is a common condition in childhood and can have a significant impact on quality of life for 
both children and parents due to itching and disturbed sleep.(3) In order for interventions to 
improve the quality of life in a way that is relevant to children and parents, it is important that the 
outcome measures used in studies capture their experiences of eczema and any perceived benefits 
of treatments  Patient reported outcome measures (PROMS) are reported directly by participants 
and are being used increasingly as primary outcomes in clinical trials in order to assess the overall 
patient experience or perception of benefit to participants.(4)   
Capturing the experiences of people with eczema is complicated by the relapsing and remitting 
nature of the condition.  Therefore, gathering information regularly over time is essential for 
understanding disease burden,(5)  and to accurately assess the impact of interventions.   
The BATHE trial aimed to assess the clinical and cost effectiveness of bath emollients for eczema.(6)  
The primary outcome was the Patient Orientated Eczema Measure (POEM) measured weekly for 16 
weeks.  POEM is the patient reported outcome measure recommended by NICE (7) and the 
international Harmonizing Outcome Measures for Eczema initiative 
(http://www.homeforeczema.org) for measuring eczema symptoms.(8)  
Although there are good reasons for collecting POEM on a weekly basis from participants, prior to 
the start of this trial there was no evidence as to whether it would be acceptable or practical to do 
so.  The study team had experience of two prior studies which had gathered data from participants 
on a daily basis.  The Softened Water Eczema Trial (SWET) had gathered POEM daily data via paper 
diaries (9).  The data were very complete with 94% of all data points complete at 16 weeks(10). 
However, with paper diaries there is a risk that participants may complete the measures at a later 
date, backfilling the diary in order to return complete data to the research team but increasing the 
risk of recall bias(11).    An observational study of flare triggers also recorded eczema on a daily basis 
but using electronic diaries.(12)  The diary could not be completed after midnight on any given day, 
thereby eliminating the risk of backfilling the diary.  But the data were much less complete, with only 
60% of the data complete at 16 weeks.(10)   
The BATHE trial aimed to reduce the burden by collecting the POEM weekly via an online platform.   
This paper reports on the acceptability and practicality of weekly data collection from participants in 
the context of an eczema trial.   
 
Methods:   
The BATHE study 
The BATHE trial was a pragmatic unmasked 2-armed randomised controlled trial in GP practices in 
England and Wales. Children aged 12 months to 11 years who met the UK Diagnostic Criteria for 
Eczema (13) and who had mild to moderate eczema according to the Nottingham Eczema Severity 
Score (14) were randomised to either standard care or bath emollients plus standard care.  
Participants were recruited from 96 practices in Wales, West of England and Southwest England.  
Further details regarding the trial, including full inclusion and exclusion criteria, can be found in the 
published protocol (6) and published study results(15).   
The primary outcome was the Patient Orientated Eczema Measure (POEM) (16) completed weekly 
for 16 weeks. POEM is a patient reported outcome based on symptoms experienced over the 
previous week, which can be completed by the child or their parent / carer. POEM includes 7 
questions about eczema symptoms over the previous week that are summed to give a score from 0 
(eczema is clear or causing no impact) to 28 (very severe eczema). POEM is recommended by NICE 
(17)and the international HOME initiative (Harmonising Outcome Measures in Eczema) and is the 
only patient reported outcome that demonstrated sufficient validity and repeatability in a 
systematic review of outcome measures for eczema(18, 19). Our primary outcome measure was 
based on repeated measures of POEM data collected weekly over 16 weeks because this reflected 
the impact of this relapsing and remitting chronic condition better than comparing outcomes at a 
single follow-up time point. In addition to collecting the POEM each week, we also asked a weekly 
question about adverse events.  Parents were encouraged to complete measures online and offered 
the option to complete on paper only if they stated that they felt online completion would be 
difficult. 
Following the baseline appointment there were no other face-to-face study visits, so efforts were 
made from the outset to ensure that participants remained engaged with the trial.  These included 
small gifts (a bath duck branded with the study logo, post-it notes and a bendy eraser) given to each 
child at the start of the study. Communication was encouraged by setting up a study website, 
posting out birthday cards for the children and Christmas cards for the families, as well as quarterly 
newsletters.  There were also incentives to encourage continued participation including a thank you 
card and £10 voucher sent to parents before the 16 week questionnaire was due, and all participants 
were eligible for inclusion in a prize draw for a tablet computer at the end of the study.   
Sample size 
The sample size for BATHE was calculated for repeated measures analysis of covariance (ANCOVA) in 
weekly POEM scores over 16 weeks. With alpha 0.05 and beta 0.1, we aimed to detect a difference 
of 2 points in the POEM over the 16 week period (s.d 7.0) based on data from the SWET trial  (9).  
This gave a sample size of 338, rising to 423 with a 20% allowance for loss to follow up.  Early data 
suggested that approximately 80% of participants in both groups were adherent to treatment 
allocation. As we were keen to report a secondary per protocol analysis in addition to a primary 
intention to treat analysis, we revised our sample size to reflect this with approval from funder, 
sponsor and Trial Steering Committee.  Assuming 80% of participants adhere to treatment allocation 
we required an additional 68 participants to retain 90% power for the per protocol analysis.  This 
gave an increased recruitment target of 491 participants.   
The primary analysis for the trial used a mixed model (for repeated measures), allowing participants 
to contribute data for all the time points for which they have completed a weekly questionnaire.  For 
this study, we have used all available data.   
Data Collection 
Participants received a unique login and entered their data online into a validated database. 
Parents/carers were notified that the weekly questionnaire was available to complete by email and 
by text/SMS on the day that it fell due. A reminder was sent 2 days later if the POEM had not been 
completed. The online questionnaires remained available for completion for a further 5 days, when 
they were replaced by the following ǁeek’s ƋuestioŶŶaiƌe. Theƌe ǁas Ŷo faĐilitǇ to Đoŵplete the 
online POEM questionnaire retrospectively once the 7-day period had elapsed. 
Parents/carers had contact with the same member of staff for the duration of the study so far as 
possible.  Questionnaire completion was monitored by the trial team and efforts were made to 
contact participants by telephone if their completion rate fell below 80%. Particular efforts were 
made to speak to those who failed to Đoŵplete the fiƌst ǁeek’s POEM, as this ǁould suggest 
difficulties with the log-in system.  Particular efforts were also made to speak to parents/carers who 
hadŶ’t Đoŵpleted the 16-week questionnaire. 
Although the online portal was designed to be accessed via a desktop computer or tablet, we 
suspected that many parents would access the website via their mobile phone.   Data on the user 
agent and referrer was automatically captured by the online platform, enabling us to describe the 
type of device from which parents/carers logged in to record the weekly data.   
Quantitative analysis 
The proportion of parents/carers who opted for online completion and the completeness of the 
data, both in terms of the number of weeks, on average, for which they completed measures and 
the overall number of data points collected from the study population have been analysed 
descriptively and graphically.  Associations between key participant characteristics and data 
completeness were explored using chi-squared tests with a 5% significance level.   
Qualitative interviews 
All parents of affected children who were assigned to the Southampton trial centre (across 3 
geographical counties in the South of England) within the first 10 weeks of the trial were contacted 
to offer an interview primarily by email, then by phone if there was no email response.  An answer 
phone message was left for the first occasion of an unanswered call, but no further messages were 
left in the further calls that were made (up to 3 per participant). 
Semi-structured interviews were undertaken with 10 parents following an interview guide.  
Interviews were carried out either face-to-face or, where the participant preferred, by telephone. 
Interviews were audio-recorded, professionally transcribed and transcripts were checked against 
recordings. An inductive thematic analysis (20) ǁas ĐoŶduĐted to eǆploƌe people’s eǆpeƌieŶĐes and 
views of participating in the BATHE study.   
Two authors (CS and MS) read the transcripts several times and produced a coding framework, 
which developed iteratively as further transcripts became available.  Disconfirming cases were 
sought. Data saturation was not achieved for all themes (e.g. motivation for participating in trials) 
but was achieved for our main theme exploring experiences of weekly data collection.   Pseudonyms 
have been applied in reporting the data and for all quotes used below. 
Results:  
482 participants were recruited from 96 GP surgeries across 3 centres: Southampton, Bristol and 
Cardiff (Southern England, West of England and Wales).  Only 4 participants withdrew from the trial.  
Invitation letters were posted from the participating GP surgeries to 12,523 children who had 
received a prescription for eczema within the previous 12 months. The mean response rate overall 
was 11.55% (3.9% - 25%): positive eligible replies, after exclusions, averaged 3.86% (0% - 14.3%) of 
invitations sent. 
Practicality 
Online weekly questionnaire completion was chosen by 429 (89.6%) participants.  Of the remaining 
53 participants, 27 (5.6%) requested paper. and 23 (4.8%) were switched from online to paper 
format after discussion with the study team.   Reasons for this primarily related to technical issues: 
some parents became discouraged after having problems logging in to the online database or issues 
with connectivity. Where parents/carers contacted the study team about this issue, they were often 
able to log-in once their password had been re-set, indicating that they had forgotten their log-in 
details (which were case-sensitive).  However it is unclear how many gave up at this point without 
reporting the problem. 
Log-in problems were occasionally compounded by a failure to understand the automated nature of 
the system and that they would be unable to go back to complete past POEMs. Some parents 
reported difficulties getting access to the family computer and there were also individual issues such 
as changing service providers, poor internet connections, as well as long family holidays. Paper Case 
report forms (CRFs) s consisted of 4 POEMs printed in A5 booklets. They were posted out monthly, 
with a covering letter and pre-paid envelope. 
The characteristics of the participants are set out in Table 1.  Although the numbers completing on 
paper were small compared to those completing online, there was no evidence of any difference in 
characteristics by method of completion.   
[TABLE 1 here] 
As shown in Figure 1, the online weekly POEM was well completed.  If all 429 participants completed 
their data as expected, we would have collected 6864 data points.  We collected 5680 data points, 
making the data 83% complete.  Only 4 participants were lost of follow-up, due to withdrawal from 
the study.  The primary analysis of the trial was therefore able to include data from 99% of the 
participants and was over 80% complete.  Given that the sample size calculation allowed for 20% of 
participants to be lost to follow up, this was well within what was required in order to provide 
adequate data for the analysis of the primary outcome.   
There was a slight increase in the percentage completed at week 16, despite the final POEM being 
embedded within a longer questionnaire.  Parents were sent a thank you card and a £10 voucher 
just before the 16 week questionnaire was due, and a reminder letter and paper copy of the 
questionnaire were posted out if the online questionnaire had not been completed within 7 days 
(n=80). 
[FIGURE 1 HERE] 
Of the 429 parents/carers completing their data online, 206 (48%) completed their weekly data 
every week for 16 weeks.   341 (79%) completed their weekly data at least 80% of the time. The 
median number of weeks completed was 15 out of 16 (IQR 13, 16).   There were no differences 
between the two trial arms with respect to completeness with a median of 15 (12,16) for the group 
allocated to the usual care arm and a median of 15 (IQR 13, 16) for those allocated to the bath 
emollient arm.  Of those who completed online, 93 (49%) in the usual care arm and 109 (47%) in the 
bath emollient arm, completed their weekly measures for all 16 weeks.   
There was no association between study arm, sex of child, age of child, ethnicity or financial 
circumstances and the completeness of the data.  (see Table 2).   Data from the group who 
completed on paper were less complete with only 42% of weekly data points completed.  Figure 2 
shows the distribution of responses over the 16 week study period.   
[FIGURE 2 HERE] 
[Table 2 Here] 
 
The webpages where parents/carers completed the POEM were designed to be completed online on 
a computer or laptop.  They could be viewed and completed on a mobile phone but were not 
designed with this in mind.  However, of the 9784 times that parents logged in to the website, 5963 
(61%) were from mobile devices.  A further 912 (9%) were from tablets whilst 2909 (30%) were from 
computers or laptops.   
Feedback from trial staff suggested the collection of weekly data was not problematic.  On average, 
they reported needing to make a total of 6-10 telephone contacts per week to remind parents to 
complete the POEM online.  Overall, approximately 25% of the sample required following up by 
telephone at some point in order to ensure that their measures were completed.  Over the course of 
the study, 274 (57%) had no direct contact with the trial team (beyond automated messages, 
newsletters, etc). 34 had contact re issues with prescriptions/meds/reactions, and 71 had contact re 
technical issues. The technical problems were the most burdensome to deal with. 
 
Trial staff felt that the efforts that had been made to engage participants with the study were helpful 
in ensuring that the weekly measures were completed.  Trial staff also believed that parents having a 
single point of contact within the trial team throughout the study also encouraged engagement.   
 Acceptability 
Nineteen parents/carers were contacted to request a qualitative interview, of whom 10 were 
interviewed: none refused but seven did not respond to repeated phone calls to try to arrange an 
interview. A further two interviews were arranged, but were cancelled by the participant. Five 
interviews were carried out face-to-face (four in the interviewees’ hoŵes, aŶd oŶe iŶ a puďliĐ 
setting) and five interviews were carried out by telephone.  All those interviewed were mothers, 
aged 32-49 years with a child aged between 2 and 8 years old.     
Almost all interviewees said they found the questionnaires quick and easy. A few mentioned that 
they didŶ’t fiŶd questionnaires difficult but were pleased that they would become less frequent as 
the trial progressed (the POEM was asked monthly between week 16 and week 52).  
Annabel gives a very typical answer: 
IŶteƌǀieǁeƌ: ͚What do you thiŶk of the ǁeekly ƋuestioŶŶaiƌes?͛ 
AŶŶaďel: ͚FiŶe…to the poiŶt-quick-Ŷo pƌoďleŵ…͛ 
 
Most iŶteƌǀieǁees said that theǇ uŶdeƌstood ǁhǇ the ƋuestioŶŶaiƌes ǁeƌe ǁeeklǇ as theiƌ Đhild’s 
eczema was variable and some actually liked completing the questionnaires as it made them 
appreciate this variation more. One person reported initially thinking that weekly questionnaires 
ǁeƌe too ŵuĐh, as she did Ŷot thiŶk that heƌ Đhild’s eĐzeŵa seǀeƌitǇ ǁould alteƌ. DuƌiŶg the 
interview, however, Louisa reports that she was able to notice differences on a weekly basis. 
Louisa: ͚ WheŶ I heaƌd that it ǁas goiŶg to ďe ǁeekly, I thought ǁell suƌely thiŶgs aƌeŶ͛t 
going to change that much, but actually, when it comes to it – ŵy little oŶe͛s skiŶ, it ƌeally 
does ĐhaŶge that ŵuĐh…So I thiŶk ǁeekly is a good iŶteƌǀal͛. 
 
One interviewee reported finding difficulty with the weekly questionnaires, as she was forgetting to 
complete them.  
IŶteƌǀieǁeƌ: ͚…What haǀe you thought of the ǁeekly ƋuestioŶŶaiƌes?͛ 
AŶŶie: ͚I͛ǀe had tƌouďle doiŶg it eǀeƌy ǁeek: yes, I look at theŵ aŶd then I – put my phone 
doǁŶ aŶd theŶ I foƌget all aďout it…It͛s ƌeŵeŵďeƌiŶg…͛ 
 
In addition to their feelings about weekly questionnaires for the first 16 weeks, parents/carers were 
asked about their feelings around the year-long nature of the trial. (Participants continued to receive 
monthly questionnaires after 16 weeks until 52 weeks). A number of interviewees reported seasonal 
variation in theiƌ Đhild’s eĐzeŵa, aŶd thought that the Ǉeaƌ-long follow up would allow this to be 
reflected in the data.  
LiŶda: ͚You need a year – I ǁould haǀe thought…Ouƌ [eĐzeŵa] ĐhaŶges iŶ eǀeƌy seasoŶ, 
depeŶdiŶg oŶ ǁhetheƌ ǁe͛ǀe got the heatiŶg oŶ… 
IŶteƌǀieǁeƌ: ͚So the faĐt it is - ͛ 
LiŶda: ͚It is a yeaƌ, it͛s ďƌilliaŶt.͛ 
 
 
Discussion: 
We found that it is both feasible and acceptable to collect repeated measures of eczema severity 
online over a 16 week period in the context of a clinical trial.  Parents/carers and trial staff gave 
positive feedback about their experience of completing the measures online.  Some participants did 
have difficulties, and 23 had to be switched to paper completion.  However, almost 90% of 
participants completed their data online, the data were 83% complete and only 4 participants were 
lost to follow-up, allowing 99% of participants to contribute at least one datapoint to the primary 
analysis.  There was no association between participant socio-demographic characteristics and data 
completeness.   
BATHE was a pragmatic trial and it was not possible to blind participants to their group allocation.  
This led to concerns that there might have been differential attrition, with participants randomised 
to usual care feeling less engaged and failing to complete measures, which may lead to biased 
results(21).  However, we did not find evidence of this.  The median number of weekly measures 
completed was 15 out of 16 weeks in both arms, suggesting that strategies to keep participants in 
both groups engaged with the study were successful.   
There was evidence that although data completion started high, with over 90% responding in the 
first week, the response rate as shown in Figure 1 declined over time, falling to just below 80% in 
weeks 11-14 of the study.  The trial design meant that resources were targeted at the final follow up 
point, when a number of other measures were due and this increased the completion rate at week 
16 to 93%.  Targetting resources at key time points, particularly during longer follow up periods, may 
help to keep participants engaged with the study and increase the completenss of the data.   
Although rates of data completion were high, the tƌial’s data collection procedures may not have 
been optimised for the methods that participants used.  Whilst the data collection was designed 
primariliy to be completed online via a computer or tablet,  61% of logins were from mobile devices.  
AĐĐoƌdiŶg to the OffiĐe foƌ NatioŶal “tatistiĐs, iŶteƌŶet aĐĐess ͞oŶ the go͟ usiŶg ŵoďile deǀiĐes has 
increased steadily over the last 5 years with 73% of adults accessing the internet from a mobile 
phone in 2017(22).  Future studies should acknowledge this trend and ensure that the data 
collection procedure is optimised for viewing and completion on a mobile device.   
Whilst using an online data collection approach did yield relatively complete data in this study, there 
were challenges.  Difficulties with logging in were one of the main reasons participants contacted 
trial staff.  Log in problems, including lost ids and passwords, may have resulted in some participants 
being put off taking part without further contact with the trial team.  In future, other secure log in 
options, such as an app or an encrypted link for each participant, might help to avoid this potential 
difficulty.     
 
Strengths and limitations: 
This study only evaluated the feasibility and acceptability of completing weekly POEM online.  As 
noted above, digital technologies and mobile phones are becoming increasingly pervasive in 
everyday life, and in future people may find it more convenient to use apps or SMS to provide 
data.(23)  Participants did receive text message reminders but could not complete their POEM 
questionnaire via text.   Although we believe that it is very likely that the feasibility of completing 
POEM weekly online would translate into these other media, this would have to be evaluated 
further.(24)   
Qualitative interviews with a larger number of participants, including participants who completed 
paper questionnaires, or purposively sampling participants with low completion rates, may have 
generated further useful insights and is planned for future trials. 
Findings in context of existing research 
The collection of repeated measures data is known to suffer from problems with attrition (25) as is 
data collected as part of studies administered online(26).  The level of completeness achieved with 
the online weekly POEM of 83% was comparable to that observed in three other recent eczema 
trials. The COMET feasibility study asked participants to complete a daily diary for 12 weeks by paper 
or using an electronic app.  Due to problems with the online app, only 11/196 participants 
completed measures using the app but POEM data were complete for between 70% and 75% of all 
participants (paper and online) over the 12 week period.(27)  The CREAM trial measured POEM at 4 
weeks and 3 months and achieved a response rate of 86.7% and 65.5% respectively(28).  The 
CLOTHES trial collected POEM weekly for 24 weeks and 85% of participants completed 12 or more of 
the weekly questionnaires(29).   
 
Weekly data collection has been used in clinical trials of other medical conditions.  A trial of weekly 
self-monitoring in asthma concluded that it improved asthma control and was feasible, with 80% 
completing the weekly data collection online as instructed during the first 3 months  (30).  Self-
monitoring is frequently included as part of behavioural weight loss interventions (31) and several 
studies have included weekly diaries to collect physical activity and nutrition information.  These 
studies have found weekly diaries to be reasonably complete – ϲϮ.ϳ% iŶ Caƌel et al.’s ϭϰ ǁeek RCT 
(32)aŶd ϴϯ% iŶ the fiƌst ϲ ŵoŶths of WiŶg et al.’s ϭϴ ŵoŶth RCT(33) .  Weekly testing has also been 
trialled for the self-management of oral anti-coagulant therapy and showed that weekly self-
management is feasible and provided some protection from complications (34).   This study 
therefore fits within an existing literature suggesting that weekly data collection can be feasible and 
acceptable in a clinical trial setting.   
 
 
Implications for future research 
It is possible that frequent assessment allows participants to provide more accurate recall and thus 
reduces bias(35).  However, it is also possible that repeatedly asking participants about eczema 
symptoms changes their perception and hence their responses, causing a response shift.(36)  It may 
alter adherence to study medications and co-treatment and introduce a performance bias if weekly 
assessment of eczema status is not part of normal routine care.  It is therefore important to evaluate 
whether in addition to being feasible and acceptable, the collection of weekly POEM is actually 
useful when compared to using measures taken at less frequent time points.  The HOME group is 
continuing to explore the best way to capture long term control of eczema (37) and the data 
gathered as part of the BATHE trial will be evaluated alongside data from other eczema trials to help 
to inform decisions about how frequently to ask participants to complete the POEM in future studies 
and over what time period.   
 
Conclusion 
In this population, weekly completion of the online questionnaire appeared to be acceptable and 
feasible over a 16 week period.  Email, text and phone reminders seemed helpful to most 
participants.   
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